Zydus receives final approval for Telmisartan and Hydrochlorothiazide Tablets

From USFDA

Zydus Cadila has received the final approval from the USFDA to market Telmisartan and Hydrochlorothiazide Tablets USP, in the strengths of 40 mg/12.5 mg, 80mg/12.5 mg and 80mg/25 mg. Telmisartan and Hydrochlorothiazide Tablets are used to treat hypertension (high blood pressure). The drug will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad.

Powered by Capital Market - Live News